Free Trial
→ Buffett, Gates and Bezos Quietly Dumping Stocks—Here's Why (From Banyan Hill Publishing) (Ad)tc pixel Free LYEL Stock Alerts

Lyell Immunopharma (LYEL) Institutional Ownership

Lyell Immunopharma logo
$12.82 -0.48 (-3.61%)
Closing price 04:00 PM Eastern
Extended Trading
$12.84 +0.03 (+0.20%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Lyell Immunopharma (NASDAQ:LYEL)

Current
Institutional Ownership
Percentage
66.05%
Number of
Institutional Buyers
(last 12 months)
41
Total
Institutional Inflows
(last 12 months)
$531.47M
Number of
Institutional Sellers
(last 12 months)
37
Total
Institutional Outflows
(last 12 months)
$896.26M
Get LYEL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lyell Immunopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

LYEL Institutional Buying and Selling by Quarter

Lyell Immunopharma Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/28/2025 China Universal Asset Management Co. Ltd.2,966$26K0.0%-94.9%0.015%
8/15/2025 Orland Properties Ltd754,698$6.67M2.8%-95.0%3.929%
8/15/2025 MWG Management Ltd.1,008,116$8.91M17.2%-95.0%5.248%
8/15/2025 HSG Holding Ltd152,299$1.35M0.1%-95.0%0.793%
8/15/2025 Boothbay Fund Management LLC12,234$108K0.0%-95.0%0.064%
8/15/2025 Bridgeway Capital Management LLC18,000$159K0.0%N/A0.094%
8/15/2025 Bank of America Corp DE23,758$210K0.0%-74.7%0.124%
8/15/2025 ARCH Venture Management LLC1,820,634$16.11M5.4%N/A9.478%
8/14/2025 Orbimed Advisors LLC51,727$457K0.0%N/A0.335%
8/14/2025 Raymond James Financial Inc.7,900$70K0.0%-95.0%0.051%
8/14/2025 Canada Pension Plan Investment Board29,411$260K0.0%-95.0%0.190%
8/14/2025 The Manufacturers Life Insurance Company 24,419$216K0.0%-95.2%0.158%
8/14/2025 RBF Capital LLC100,000$884K0.0%N/A0.647%
8/13/2025 Marshall Wace LLP10,580$94K0.0%N/A0.068%
8/13/2025 Walleye Capital LLC29,230$258K0.0%N/A0.189%
8/13/2025 Decheng Capital LLC595,466$5.26M1.2%-95.0%3.852%
8/13/2025 Invesco Ltd.12,809$113K0.0%-96.6%0.083%
8/12/2025 Foresite Capital Management V LLC406,652$3.60M4.5%-95.0%2.630%
8/12/2025 Foresite Capital Management IV LLC800,399$7.08M5.7%-95.0%5.177%
8/12/2025 JPMorgan Chase & Co.3,369$30K0.0%-98.3%0.022%
8/8/2025 Geode Capital Management LLC103,270$913K0.0%-97.7%0.668%
8/8/2025 Takeda Pharmaceutical Co. Ltd.41,165$364K1.9%-95.0%0.266%
8/1/2025 Alphabet Inc.293,256$2.59M0.1%-95.0%1.980%
7/28/2025 TD Asset Management Inc50,232$444K0.0%-95.0%0.339%
7/22/2025 Johnson & Johnson41,165$368K0.1%-95.0%0.278%
7/22/2025 Clarius Group LLC19,138$169K0.0%-95.2%0.129%
6/27/2025 Goldman Sachs Group Inc.358,592$193K0.0%-42.8%2.421%
6/18/2025 Voya Investment Management LLC50,329$27K0.0%-4.9%0.340%
5/29/2025Rhumbline Advisers235,694$127K0.0%-16.2%0.080%
5/21/2025Acadian Asset Management LLC660,899$354K0.0%+204.2%0.224%
5/19/2025Jane Street Group LLC64,241$35K0.0%-73.2%0.022%
5/16/2025Goldman Sachs Group Inc.358,592$193K0.0%-42.8%0.121%
5/16/2025Jacobs Levy Equity Management Inc.558,979$301K0.0%-59.6%0.189%
5/16/2025AQR Capital Management LLC174,279$94K0.0%+773.5%0.059%
5/16/2025Almitas Capital LLC2,482,606$1.34M0.4%+136.3%0.841%
5/12/2025Nuveen LLC641,173$345K0.0%N/A0.217%
5/12/2025Invesco Ltd.378,880$204K0.0%-7.0%0.128%
5/9/2025Charles Schwab Investment Management Inc.1,604,676$863K0.0%-2.5%0.543%
4/17/2025Exchange Traded Concepts LLC246,349$133K0.0%+82.4%0.083%
4/8/2025Rhumbline Advisers235,694$127K0.0%-16.2%0.080%
2/19/2025Public Employees Retirement System of Ohio99,307$64K0.0%N/A0.034%
2/17/2025venBio Partners LLC7,102,190$4.55M2.7%N/A2.431%
2/17/2025Two Sigma Investments LP204,501$131K0.0%-15.4%0.070%
2/17/2025Two Sigma Advisers LP306,400$196K0.0%+143.8%0.105%
2/17/2025Nuveen Asset Management LLC641,173$410K0.0%-25.1%0.219%
2/17/2025Orbimed Advisors LLC3,103,623$1.99M0.0%-49.0%1.062%
2/17/2025Millennium Management LLC957,507$613K0.0%+34.8%0.328%
2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.308,551$197K0.0%+13.4%0.106%
2/17/2025Jacobs Levy Equity Management Inc.1,385,301$887K0.0%N/A0.474%
2/17/2025Graham Capital Management L.P.52,136$33K0.0%N/A0.018%
2/17/2025Foresite Capital Management V LLC8,133,047$5.21M4.3%N/A2.784%
2/17/2025D. E. Shaw & Co. Inc.966,265$618K0.0%+104.4%0.331%
2/17/2025BNP Paribas Financial Markets253,669$162K0.0%N/A0.087%
2/17/2025Almitas Capital LLC1,050,520$672K0.1%N/A0.360%
2/14/2025Jane Street Group LLC239,439$153K0.0%-16.8%0.082%
2/14/2025Northern Trust Corp1,310,224$839K0.0%-3.4%0.448%
2/14/2025Decheng Capital LLC11,909,341$7.62M1.6%N/A4.076%
2/14/2025Boothbay Fund Management LLC406,234$260K0.0%+190.4%0.139%
2/14/2025Price T Rowe Associates Inc. MD6,910,749$4.42M0.0%-6.0%2.365%
2/14/2025Johnson & Johnson823,317$527K0.1%N/A0.282%
2/13/2025Barclays PLC258,380$165K0.0%+7.4%0.088%
2/13/2025Renaissance Technologies LLC1,612,146$1.03M0.0%+716.7%0.552%
2/13/2025Wells Fargo & Company MN94,320$60K0.0%+27.8%0.032%
2/12/2025RPO LLC66,378$42K0.0%N/A0.023%
2/12/2025Geode Capital Management LLC4,137,264$2.65M0.0%+2.9%1.416%
2/12/2025Takeda Pharmaceutical Co. Ltd.823,317$527K2.0%N/A0.282%
2/12/2025JPMorgan Chase & Co.433,265$277K0.0%+347.8%0.148%
2/11/2025Prudential Financial Inc.48,057$31K0.0%-66.8%0.016%
2/6/2025Charles Schwab Investment Management Inc.1,645,787$1.05M0.0%+43.4%0.563%
1/17/2025SG Americas Securities LLC116,748$75K0.0%+102.8%0.040%
11/19/2024Barclays PLC240,615$332K0.0%+312.7%0.082%
11/15/2024Barclays PLC240,615$332K0.0%+312.7%0.086%
11/15/2024Jane Street Group LLC287,717$397K0.0%+63.7%0.103%
11/15/2024State Street Corp3,889,553$5.37M0.0%+1.9%1.393%
11/15/2024Centiva Capital LP22,160$31K0.0%N/A0.008%
11/15/2024Point72 Asia Singapore Pte. Ltd.37,704$52K0.0%N/A0.014%
11/15/2024Erste Asset Management GmbH54,000$82K0.0%N/A0.019%
11/14/2024MetLife Investment Management LLC36,287$50K0.0%-57.5%0.013%
11/13/2024FMR LLC1,024,583$1.41M0.0%-62.5%0.367%
11/12/2024Charles Schwab Investment Management Inc.1,147,370$1.58M0.0%-11.6%0.448%
11/9/2024Intech Investment Management LLC37,495$52K0.0%N/A0.015%
11/8/2024WuXi AppTec Co. Ltd.7,390,710$10.20M53.6%-3.8%2.887%
11/6/2024Cornercap Investment Counsel Inc.47,763$66K0.0%-50.4%0.019%
11/5/2024Baillie Gifford & Co.141,949$196K0.0%-72.7%0.055%
11/5/2024GSA Capital Partners LLP354,815$490K0.0%+1,285.5%0.139%
10/25/2024China Universal Asset Management Co. Ltd.49,238$68K0.0%+64.4%0.019%
10/10/2024Exchange Traded Concepts LLC135,050$186K0.0%+37.3%0.053%
10/3/2024SG Americas Securities LLC57,566$79K0.0%+78.1%0.023%
8/15/2024Susquehanna Fundamental Investments LLC128,203$186K0.0%+49.5%0.050%
8/15/2024The Manufacturers Life Insurance Company553,163$802K0.0%+14.4%0.217%
8/14/2024ProShare Advisors LLC38,982$57K0.0%-20.4%0.015%
8/12/2024XTX Topco Ltd70,174$102K0.0%-36.6%0.028%
8/9/2024Renaissance Technologies LLC152,300$221K0.0%-64.0%0.060%
8/9/2024Dimensional Fund Advisors LP40,098$58K0.0%+197.8%0.016%
8/9/2024Massachusetts Financial Services Co. MA577,319$837K0.0%-62.5%0.226%
8/8/2024American Century Companies Inc.279,425$405K0.0%+18.1%0.110%
8/6/2024WuXi AppTec Co. Ltd.7,682,156$11.14M47.7%-6.1%3.013%
8/3/2024TD Asset Management Inc1,004,642$1.46M0.0%+4.2%0.394%
8/1/2024Rhumbline Advisers260,742$378K0.0%-6.3%0.102%
7/29/2024Principal Financial Group Inc.26,510$38K0.0%-54.5%0.010%
(Data available from 1/1/2016 forward)

LYEL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of LYEL shares?

During the previous two years, 95 institutional investors and hedge funds held shares of Lyell Immunopharma. The most heavily invested institutionals were Vanguard Group Inc. ($29.86M), ARCH Venture Management LLC ($16.11M), WuXi AppTec Co. Ltd. ($10.20M), MWG Management Ltd. ($8.91M), Opaleye Management Inc. ($7.48M), Foresite Capital Management IV LLC ($7.08M), and Orland Properties Ltd ($6.67M).Learn more on Lyell Immunopharma's institutional investors.

What percentage of Lyell Immunopharma's stock is owned by institutional investors?

66.05% of Lyell Immunopharma's stock is owned by institutional investors. Learn more on LYEL's institutional investor holdings.

Which institutional investors have been buying Lyell Immunopharma's stock?

Of the 64 institutional investors that purchased Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Decheng Capital LLC ($11.91M), WuXi AppTec Co. Ltd. ($8.18M), Foresite Capital Management V LLC ($8.13M), venBio Partners LLC ($7.10M), Opaleye Management Inc. ($3.36M), Almitas Capital LLC ($2.48M), and ARCH Venture Management LLC ($1.82M).

How much institutional buying is happening at Lyell Immunopharma?

Institutional investors have bought a total of 41,309,945 shares in the last 24 months. This purchase volume represents approximately $531.47M in transactions.

Which of Lyell Immunopharma's major shareholders have been selling company stock?

Of the 37 institutional investors that sold Lyell Immunopharma's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: MWG Management Ltd. ($19.15M), Foresite Capital Management IV LLC ($15.21M), Orland Properties Ltd ($14.34M), Decheng Capital LLC ($11.31M), Foresite Capital Management V LLC ($7.73M), Alphabet Inc. ($5.57M), and Geode Capital Management LLC ($4.30M).

How much institutional selling is happening at Lyell Immunopharma?

Institutional investors have sold a total of 93,711,474 shares in the last 24 months. This volume of shares sold represents approximately $896.26M in transactions.


Related Companies

This page (NASDAQ:LYEL) was last updated on 9/12/2025 by MarketBeat.com Staff
From Our Partners
Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...
Paradigm Press | Sponsoredtc pixel
Critical AI announcement set to ignite AI 2.0
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsoredtc pixel
Forget NVDA. Put $1,000 into this stock now
A massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...
Chaikin Analytics | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Out of 18,347 Cryptocurrencies... This is the ONLY One
The Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...
Crypto 101 Media | Sponsoredtc pixel
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsoredtc pixel
Do NOT Day Trade (Do THIS instead)
Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...
Monument Traders Alliance | Sponsoredtc pixel
Wall Street laughed at Trump’s “Smart Dollar.” Now they’re all in.
"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...
Stansberry Research | Sponsoredtc pixel